DS
CPHI icon

DRW Securities’s China Pharma Holdings CPHI Stock Holding History

DRW Securities’s Portfolio CPHI Stock Details CPHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,423
Closed -$21.1K – 1375
2025
Q4 		$21.1K Buy
+17,423
New +$28.6K ﹤0.01% 1165

Other funds holding CPHI

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

DRW Securities's CPHI Position: Q1 2026 in Review

DRW Securities sold out of China Pharma Holdings (CPHI) in Q1 2026, closing a stake of 17,423 shares — an estimated $21.1K sold.

DRW Securities first reported a position in CPHI in Q4 2025 and held it in 1 quarter. The position peaked at $21.1K in Q4 2025. 6 funds tracked by Wall St. Rank hold CPHI as of Q1 2026.

  • DRW Securities reported no remaining China Pharma Holdings position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 17,423 China Pharma Holdings shares in Q1 2026, an estimated $21.1K.
  • DRW Securities first reported a position in China Pharma Holdings in Q4 2025 and held it in 1 quarter.
  • DRW Securities's China Pharma Holdings position peaked at $21.1K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held China Pharma Holdings as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.